NCT01446679

Special Drug Use-Results Survey of Lipitor Tablets

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 24,050 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This study is to evaluate the controlling effect of atrovastatin on plasma lipid to achieve the category-specific targeted lipid levels.

Detailed description

To confirm the low-density lipoprotein cholesterol (LDL-C)-lowering effect of 24 weeks of treatment with Lipitor®(Generic Name : atorvastatin calcium) Tablets and determine the rate of achievement of the category-specific target LDL-C level in patients with hypercholesterolemia; and to confirm the usefulness (efficacy and safety) of atorvastatin in patients who have not responded sufficiently to other statin therapies

Conditions

• Hypercholesterolemia

Interventions

Type	Name	Description
DRUG	atrovastatin	oral

Timeline

• Start date: 2010-09-01
• Primary completion: 2012-03-01
• Completion: 2012-03-01
• First posted: 2011-10-05
• Last updated: 2013-02-21

Locations

8 sites across 1 country: Japan